The Board of Directors in their meeting held today have approved the Audited Standalone Financial Results for the financial year 2024-25 ended on 31st March, 2025. Pursuant to Regulation ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Promact Impex Limited (BSE: 526494) announced audited standalone results for FY25 on May 19, 2025, with the board approving them in a meeting that lasted 30 minutes. Revenue from operations fell sharply to Rs. 91.43 lakh from Rs. 177.92 lakh in FY24, a year-on-year decline of about 49%. Profit after tax dropped even more steeply to Rs. 12.56 lakh from Rs. 90.07 lakh (around 86% decline), translating to EPS of Rs. 0.19 versus Rs. 1.38 earlier. Auditor M/s. Fenil P. Shah & Associates issued an unmodified opinion with no qualifications. Notably, the company's reserves remain deeply negative at Rs. (833.94) lakh, leaving total equity at Rs. (182.76) lakh, indicating accumulated losses exceed share capital.
Sharp revenue and profit collapse, combined with a negative net worth of Rs. 182.76 lakh, is a serious red flag for shareholders despite the clean audit report. Expect potential selling pressure and weak investor sentiment on the stock.